Endo Fellow

[Circulation @CircAHA]

Patients with LVAD demonstrate substantial cardiomyocyte regeneration, highlighting a potential therapeutic avenue @frisenjonas @Joseph_Taleb @SJovinge @ThirupuraShank1 @CPKyriakopoulos @mandra @oibergmann https://t.co/U2RQhzLSTo

[Scott Isaacs @scottisaacsmd]

GLP-1 medications are associated with lower rates of opioid overdose and alcohol intoxication.
https://t.co/UpijMWBUXn

[Dr. Simon @goddek]

Thank you for reading this thread! If you found it informative, please share it so others can benefit from this critical information too. Let's spread the truth about what's in our food and help more people make healthier choices. Thank you!
https://t.co/HOQooQu8jD

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

#2hPG appears better than #HbA1c in detecting #dysglycaemia and predicting its impact on future #cardiovascular events in patients with #coronary artery disease and should be recommended as the primary screening tool https://t.co/N4zxybWedh #CVD #CAD #T2D

[NIH @NIH]

The MIND diet, a diet that has key elements of the Mediterranean and DASH diets, was linked to reduced risk of cognitive decline in a recent #NIH-supported study. https://t.co/zd7SCfbXgi

[Endo Fellow @endo_fellow]

Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies - The Lancet Diabetes & Endocrinology https://t.co/ETbyrSS90S

[Dr Robert Kushner @DrRobertKushner]

Excited to share our recent JAMA review article on #obesity medications. @gudzune @ConscienHealth
@NMEndocrinology @NMHC_News

[Daniel J Drucker @DanielJDrucker]

In 2867 women with #obesity and a median follow-up of 23.9 years, bariatric surgery was associated with lower incidence of #breastcancer compared to usual obesity care #cancer

[Scott Isaacs @scottisaacsmd]

Bariatric surgery compared with medical/lifestyle intervention had superior glycemic control with less diabetes medication use and higher rates of diabetes remission after a 7-12 year follow up.
https://t.co/jeC9eBTgMf

[NEJM @NEJM]

3. Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity https://t.co/lNjqjAF5oc #Endocrinology

[Daniel J Drucker @DanielJDrucker]

A new review. Liraglutide and semaglutide use after bariatric surgery #weightloss https://t.co/QB4Hq1pzHm

[Scott Isaacs @scottisaacsmd]

Over the last decade, 65% of adults with diabetes were treated with medications that cause weight gain and only 13.5% were treated with medications that induce weight loss.
https://t.co/suENEFAww4

[SCOPE @SCOPEObesity]

'Genetics and Obesity', our newest SCOPE E-Leaning module, provides a comprehensive overview of how genetic changes contribute to obesity. 🧬

This module is free to access and is available in English, French, Spanish and Portuguese.

➡️ Learn more: https://t.co/XmxG1SGfyN

[Michelle Vicari @Eggface]

Happy Halloween! 🎃 You know what's scary? Not having any or adequate health insurance.

Be sure yours has the #obesity coverage you need https://t.co/V6vswId4Ww #openenrollment #HealthInsurance

[Endo Fellow @endo_fellow]

Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial https://t.co/AtAvVDPUiX

[JAMA @JAMA_current]

Early metformin initiation did not reduce the occurrence of the combination of a fasting glucose level of 92 mg/dL (5.1 mmol/L) or greater at gestation weeks 32 or 38 or insulin initiation. Follow-up for rates of small for gestational age is needed. https://t.co/J8or4W88qm

[Endo Fellow @endo_fellow]

GLP-1 Agonists and Gastrointestinal Adverse Events https://t.co/OtF8oXE7RA

[Neil Floch MD @NeilFlochMD]

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension - Wilding - 2022 - Diabetes, Obesity and Metabolism - Wiley Online Library https://t.co/hg3AXWushU

[James Dornbush @JamesDornbush]

My first publication! Check out our review on the significant impact male obesity has on fertility, including decreased sperm parameters, rates of natural conception, and ART outcomes. Grateful for the opportunity and for such a supportive team.
https://t.co/X7Ny6qSVge

[Karl Nadolsky @DrKarlNadolsky]

Tirzepatide induces more than 19% weight loss for adults with obesity and heterozygous MC4R deficiency https://t.co/QzsYsD15wh